From regulatory compliance to collaborative platforms like Pharma.Aero, explore how industry experts are navigating the complexities of ATMP logistics and paving the way for a more efficient and effective healthcare delivery system. Join Frank Van Gelder and his guest, Olivier Mary, Chief Commercial and Supply Project Director of Euromed Pharma, shedding light on the crucial role of precision logistics in delivering cutting-edge therapies to those in need. Tune in for insights, expertise, and a glimpse into advanced therapy logistics.

Tune in for a thought-provoking episode filled with insights on leveraging real-time data and AI to optimize inventory management, streamline logistics, and enhance supply chain resilience.Join Frank Van Gelder and his guests▪️ Mark van Os de Man, Global Air Freight Product Director Healthcare at Hellmann Worldwide Logistics ▪️ Richard Peck, Global Director of Compliance and Regulatory Affairs at OnAsset Intelligence Key highlights:The importance of understanding customer needs for tailored technology solutionsReal-time asset tracking and temperature monitoring in the supply chainOpportunities and challenges in adopting predictive analytics and AIThe crucial role of human factors in implementing next-gen technology

Join Frank Van Gelder and his guests ▪️ Jaisey Yip, Vice President Cargo Business Division at Changi Airport Group▪️ Walter Soriano, Senior Manager of Sustainability and Market Intelligence for Global Logistics and Network Services at Pfizer"Sustainability is becoming a key element for enhancing our relationships with service providers. We are aiming to achieve our sustainability objectives by partnering with our key suppliers, and this means that we are obviously sending the right signals to all our key suppliers, trying to bring them on board. We are already tracking this on a monthly basis. In order to also report our performance, we need to make sure that our service providers are performing as they claim. Indeed, this is something we are taking very seriously in different aspects.""Decarbonising aviation as well as air cargo requires collective efforts across the value chain. If you look from an air hub perspective, aviation authorities and airport authorities, we - as an airport - are in a way natural conductors and orchestrators in setting out a common vision for the community, setting out a common target as well as a concrete action plan."

The drive for everything happening in the life science and MedTech industries is determined by humanity and its increasing need for healthcare. The customer, or in other words, the patient’s illness will steer the innovations and the related supply chain model and logistics. What are the three major trends influencing healthcare and its innovations in the foreseeable future? Tune in for a thought-provoking discussion with Frank Van Gelder, Secretary General of Pharma.Aero,  and get prepared for future healthcare logistics. Critical trend - the rapid growth of the global population: "We have reached 8 billion people and it's growing faster even as we speak. And probably by the end of 2024, we would have 8.2 billion people." Major challenge - reaching underserved regions with essential treatments: "The second biggest challenges will be seen in how to bring treatments, how to bring medication to at this moment still very difficult to reach areas in the world." Emphasizing the need for orchestrated collaboration among stakeholders to streamline healthcare logistics processes: "You need different stakeholders that are orchestrated in one standard way to make sure that from manufacturing the treatment or the drug or the vaccine or the therapy to deliver it to the patient you have at least five to nine to eleven stakeholders involved." Underscoring logistical hurdles: "If you look at Sub-Saharan Africa, only three to four airports are at this moment capable of receiving different types of treatment." The transformative potential of advanced therapies like Advanced Therapy Medicinal Products (ATMP) in revolutionizing healthcare delivery: "It's wider than only one thing. So I think if you look at the newest drugs that come to the market, let's name them, ATMP, Advanced Therapy Medicinal Products, that are very, very promising in the treatment of cancer." The potential of artificial intelligence (AI) to enhance healthcare logistics by predicting supply chain outcomes and optimizing delivery routes: "AI is an accelerated use of data and analytics to improve healthcare treatments." April, 2024

Gain invaluable insights into the multifaceted approach to sustainability within the pharmaceutical industry and discover how diverse stakeholders can collaborate to address its most critical aspects. Join Frank Van Gelder and his guests offering first-hand accounts of their efforts to drive sustainability forward:Janet Wallace, Managing Director Cargo Operations & Transformation, Air CanadaKristof De Smedt, Global Business Unit Director, Cold Chain Technologies"How we look at sustainability is to help the life science healthcare industry to optimize packaging but not downplaying performance. Quality is paramount, we should not give in on the performance of our products but we are indeed actively looking to reuse solutions, find other insulative materials, etc.""I don't think we can turn a blind eye to it. From my perspective, the customer is going to take me there regardless, so I need to get on board and better understand what all these requirements are and figure out how I'm going to try to meet those requirements. So there's a lot of education to be done.""Sustainability and acting aligned with that is going to come as a condition of employment. If we can't follow that trend or we cannot actively participate, we will basically be out of business, because it's around us. There are a lot of ideas, but I see that there is no strict standard yet. There is a lot of talk on CO2 reduction, etc., but there's no clear guideline yet, so that will come, but the early adopters will be the ones that continue and have a long-term plan.""I think the gap between packaging solutions and the airline is the customer. The customer is driving where my attention is going to be focused. They evaluate the airlines based on the trade lanes and our ability to become sustainable. So when we're looking to compete within the marketplace, we need to meet the customer expectations and the customer is detailing exactly where we need to be.""We need to get to the point where we're looking at empty miles, what's moving around the planet and how is it coming back. The reverse logistics becomes paramount." "The earlier you start the discussion with all the stakeholders, the better the solution that comes out. Not all airports are created equal, and not all handlers are created equal, so even when we participate in the evaluation of the trade lanes, sometimes we have the aircraft, we have the packaging, and we have the customer, but we just don't have the handling capabilities to meet that and we have to opt-out. Because that's the truth.""Anybody who's going to be developing a plan to participate in any kind of mitigations is going to have to have a long view and make some investments up front that will only benefit us in the long term. And those are difficult business cases to build and pass along because everybody wants to reap the rewards immediately."

Join Frank Van Gelder and his guests in exploring regional and global challenges of healthcare logistics, spotlighting the unique challenges faced by two distinct markets – India and Brazil.Hugo Repolho - Head of Commercial and Strategy Air Cargo at Guarulhos Airport in BrazilTushar Jani - Group Chairman of Cargo Service Centre India Glyn Hughes - Director General, TIACARegional Growth ChallengesIndia's Position as the Global PharmacyCapacity Upliftment and ConnectivityInfrastructure and Challenges in Air CargoSustainability and Environmental ImpactThe Role of ESG in Pharma LogisticsThe Importance of Collaboration and Insights SharingPodcast host: Frank Van Gelder, Secretary General of Pharma.Aero

Four university professors are discussing the crucial collaboration between academia and the industry in life science supply chain logistics in a highly interactive podcast moderated by Frank Van Gelder. Guests: - Koen Vandenbempt, Dean of the Faculty of Business and Economics, University of Antwerp- Lynette Cheah, Associate Professor, Engineering Systems and Design, Singapore University of Technology and Design- Wouter Dewulf, Professor Doctor, Academic Director C-MAT – Master in Maritime and Air Transport Management, University of Antwerp- Christa Sys, Professor Doctor, Holder of the BNP Paribas Fortis Chair of Transport, Logistics and Ports at the University of Antwerp Recorded in Singapore, during the Pharma Logistics Masterclass 2023 - Where Business Meets AcademicsLearn more about the Pharma Logistics Masterclass here Pharma Logistics Masterclass 2024 - Pharma.Aero - We connect pharmaHighlights of the podcast:- The collaboration between academia and the industry ensures a better understanding of the practical needs of the business segment and a better use of science and research for very practical and impactful outcomes.- Collaborating with the industry offers universities significant potential in curriculum evaluation and research opportunities. - The industry gets to know the latest developments and research. Also, they might have projects to pass on to students. - Challenges: sometimes, a lack of patience, as the companies are used to having very quickly reports from consultants. At the academic level, it is rather slower research. - The academics can support the business, and help them structure the challenges, and identify opportunities and threats. "We cannot do research, especially on our field, which is supply chain management, out of an ivory tower. For us particularly, networking is absolutely key.""Connecting with the industry segment is tremendously important: it opens doors for yourself, for your research, but also for the students, for internships."

Join Frank Van Gelder and his guests as they explore the arrival of the new generation of digital technologies in life science logistics, with the very valuable insights of pharmaceutical manufacturers. Guests:-        Veerle Vermeiren, Director, Production Planning Puurs, Pfizer -        Ruud van der Geer, Associate Director, Supply Chain Management, Global Delivery Strategy Team, MSD-        Lila Ridouh, Manager of Distribution and Quality,  GSKPodcast host: Frank Van Gelder, Secretary General of Pharma.Aero

Navigating challenges in the ever-evolving pharmaceutical landscape - from adapting to new therapies to addressing sustainability, the dialogue explores the intersection of innovation, sustainability, and responsiveness in the industry.Guests:Diego Loaiza, Director - Global DIMS Applications, Cold JetMohamed Nouh, Business Development Director SECURE, SkyCellLaetitia Chery, Europe Middle East Africa Pharma & Healthcare Director Sales, JAS Worldwide Moderator: Frank Van Gelder, Secretary General of Pharma.Aero

How is the logistics sector responding to the development of new types of therapies and different innovations that are challenging the industry? Join us to learn how various stakeholders, from airports to airlines and freight forwarders, guarantee the fast implementation of new approaches and ensure that the airfreight industry can fit the bigger picture of a logistics multi-modal ecosystem.Guests: Zhong Yao Liew, General Manager, Cargo Logistics Development, Changi Airport GroupMiguel Rodriguez, Head of Cargo Products, Qatar AirwaysGino Marzola, Managing Director, DSV Air & Sea Singapore & MalaysiaModerator: Frank Van Gelder, Secretary General of Pharma.Aero

In this episode, we dive deep into the arrival of the new generation of digital technologies in life science logistics. Join host Frank van Gelder as he brings together experts from pharmaceutical manufacturing: 🎙️ Cesar Gil Martinez - Procurement Regional Manager, Europe, Middle East, and Asia, Transportation and Warehousing at Bayer🎙️ Roland Yap - Asia-Pacific Head of Policy Partnerships and Healthcare Systems at Novartis🎙️ Gergely Szorcsik - Director Global Distribution at ZoetisDiscover how data and power data analytics have become a new asset, influencing various aspects of the pharmaceutical industry, from logistics to sustainability. These leaders share their perspectives on AI, machine learning, and their impact on different processes in R&D and production standards. Explore the regulatory challenges, ethical considerations, and the importance of human skills in this rapidly evolving landscape. Listen in as our experts discuss the future of healthcare, data quality, and the role Pharma.Aero plays in shaping the logistics industry.

Learn more about the Pharma Logistics Masterclass taking place from 29 September to 3 October in Dallas Fort Worth, TX, US - Where Business Meets AcademicsGuests: Trevor Caswell - Chairman of Pharma.Aero, Prof. Dr Roel Gevaers - University of Antwerp, Milton De La Paz - Dallas Fort Worth International Airport, co-organizer of the 2024 Pharma Logistics MasterclassModerator: Frank Van Gelder, Secretary General of Pharma.AeroStay tuned for updates on the PLMC program and speakers on www.pharma.aero

Unveiling the path to pharma sustainability through the lens of the pharmaceutical manufacturer MSDRuud van der Geer, Associate Director of Supply Chain Management at MSD, provides a comprehensive exploration of sustainability in pharmaceutical distribution and logistics. The interview sheds light on a range of strategies for optimizing freight, reducing emissions, and embracing more sustainable practices.

A thought-provoking conversation about environmental sustainability along the healthcare supply chain with   - Damien de Chillaz, CEO and Co-founder KatalX - Fabrice Panza, Manager Cool Chain Solutions Etihad Cargo- Andy Faes, Regional Manager Healthcare Vertical Europe Expeditors Find out more about Pharma.Aero, our leading global collaborative platform's members and projects on www.pharma.aeroWhat are the sustainability objectives and practices in each segment? What are the costs involved in achieving them? And, perhaps most importantly, do they have a choice in prioritizing sustainability?

Pharma.Aero’s collaborative podcast explores the complexity of the life sciences and med tech supply chain, with the valuable contribution of Pharma.Aero global community of members and partners, representing the end-to-end healthcare supply chain. Episode 2 Guests:- Jacques Le Comte, Business Development Manager - Topa Thermal- Samuel Speltdoorn, Business & Network Development Manager Cargo - Brussels Airport- Miro Skorepa, COO and Co-founder - Hive ZoxInterviewed by Alice IacobescuIntroduction by Frank Van Gelder, Secretary General of Pharma.aero The podcast series on Sustainability delves into the concept of environmental sustainability and its significance for different stakeholders within the healthcare supply chain. What are the sustainability objectives and practices in each segment? What are the costs involved in achieving them? What are the challenges faced by various stakeholders from different segments of the supply chain?

Pharma.Aero's first episode of the podcast series about Environmental Sustainability delving into the concept of environmental sustainability and its significance for different stakeholders within the healthcare supply chain. What are the sustainability objectives and practices in each segment? What are the costs involved in achieving them? And perhaps most importantly, do we have a choice in prioritizing sustainability?Guests: Darrel Chong, of PSA BDP, Andreas Behnke of Swissport, and Florence Lehec of Emball'iso, interviewed by Alice Iacobescu